medigraphic.com

2015, Number 2

<< Back Next >>

Rev Hum Med 2015; 15 (2)

Ketogenic diet in the treatment of the refractory epilepsy in children

Varcasia MI, Lorenzo PE, Garcia AD

Language: Spanish
References: 22
Page: 373-381
PDF size: 210.10 Kb.


ABSTRACT

A descriptive study with objective to characterize the ketogenic diet as alternative in the treatment of the refractory epilepsy in children for elevating their quality of life, with the consequent decreasing of its economic cost, was carried out. The catastrophic or refractory epilepsy is one health social problem that the pediatric patient suffers, generally in the first days of life, the hard control and with numerous crisis despite of the use of antiepileptic drugs in toxic doses, and include different syndromes and diseases with own characteristics. This diet offers one hope, and its solution represents a social value because the benefit overcomes the cost for those patients that resist the drug treatment.


REFERENCES

  1. Macías Llanes ME. Educación ciencia-tecnología-sociedad en la formación general integral del profesional de la salud. En: Núñez Jover J, Macías Llanes ME, compiladores. Reflexiones sobre Ciencia, Tecnología y Sociedad. La Habana: Editorial Ciencias Médicas; 2007. p. 274-98.

  2. Aguirre del Busto R, Álvarez Vázquez J, Armas Vázquez AR, Araujo González R, Bacallao Gallestey J, Barrios Osuna I, et al. Lecturas de Filosofía, Salud y Sociedad. La Habana: Ecimed; 2000.

  3. Appleton DB, Vivo DC de. An animal model for the Ketogenic diet: Electroconvulsive threshold and biochemical alterations consequent upon a high fat diet. Epilepsia. 1974;15:211-27.

  4. Joshi SM, Singh RK, Shellhaas RA. Advanced treatments for childhood epilepsy: beyond antiseizure medications. JAMA Pediatr [Internet]. 2013 [cited 2013 Mar 25];167(1):73-86. Available from: http://archpedi.jamanetwork.com/article.aspx?articleid=1390785

  5. Livingston S. Comprehensive management of epilepsy in infancy, childhood and adolescence. Springfield: Charles C. Thomas; 1972.

  6. Kinman SL, Vining EPG, Quaskey SA, Mellits D, Freeman JM. Efficacy of the Ketogenic diet for intractable seizure disorder: Review of 58 cases. Epilepsia. 1992;33:1132-6.

  7. Tigerholm J, Börjesson SI, Lundberg L, Elinder F, Fransén E. Dampening of hyperexcitability in CA1 pyramidal neurons by polyunsaturated fatty acids acting on voltage-gated ion channels. PLOS One [Internet]. 2012 [cited 2013 Mar 25];7(9). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458057/pdf/pone.0044388.pdf

  8. Vieker S, Schmitt J, Längler A, Schmidt W, Klepper J. Unusual sensitivity to steroid treatment in intractable childhood epilepsy suggests GLUT1 deficiency syndrome. Neuropediatrics One [Internet]. 2012 [cited 2013 Mar 25];43(5):275-8. Available from: https://www.thieme-connect.com/DOI/DOI?10.1055/s-0032-1324399

  9. Rojas Ochoa F. El componente social de la salud pública en el siglo XXI. En: Núñez Jover J, Macías Llanes ME, compiladores. Reflexiones sobre Ciencia, Tecnología y Sociedad. La Habana: Editorial Ciencias Médicas; 2007. p. 210-18.

  10. Mike EM. Practical guide and dietary management of children with seizures using the ketogenic diet. Am J Clin Nutr. 1965;17:399-409.

  11. Vaccarezza M, Silva W, Maxit C, Agosta G. Super-refractory status epilepticus: treatment with ketogenic diet in pediatrics. Rev Neurol [Internet]. 2012 [cited 2013 Mar 28];55(1). Available from: http://www.revneurol.com/sec/resumen.php?or=pubmed&id=2011700

  12. Llambies Wolf J. Los desafíos inconclusos de la salud y las reflexiones para el futuro en un mundo globalizado. En: Núñez Jover J, Macías Llanes ME. Reflexiones sobre Ciencia Tecnología y Sociedad. La Habana: Editorial Ciencias Médicas; 2007. p.173-93.

  13. Schwartz RH, Eaton J, Bower BD, Aynsley Green A. Ketogenic diet in the treatment of epilepsy: Short term clinical effects. Dev Med Child Neurol. 1989;31:145-51.

  14. Nordli DR, Koenigsber D, Carrol J, Vivo DC de. Successful treatment of infancy with the ketogenic diet. Ann Neurol. 1995;38:523.

  15. Keith HM. Convulsive disorders in children: With reference to treatment with Ketogenic diet. Boston: Little Brown; 1963.

  16. Ros P, Zamarron I, Aparicio M, Sastre A. Valoración de la efectividad de la dieta cetogénica con triglicéridos de cadena media en el tratamiento de la epilepsia refractaria en niños. A propósito de una casuística. An Esp Pediatr. 1989;30:155-8.

  17. Carroll J, Koenigsberger D. The Ketogenic diet: a practical guide for caregivers. J Am Diet Assoc. 1998;98:316-21.

  18. Ketogenic diets in the treatment of epilepsy. Drug Ther Bull [Internet]. 2012 [cited 2013 Mar 28];50(6). Available from: http://dtb.bmj.com/content/50/6/66.long

  19. Gramer G, Wolf NI, Vater D, Bast T, Santer R, Kamsteeg EJ, et al. Glucose transporter-1 (GLUT1) deficiency syndrome: diagnosis and treatment in late childhood. Neuropediatrics [Internet]. 2012 [cited 2013 Mar 28];43(3):168-1. Available from: https://www.thieme-connect.com/DOI/DOI?10.1055/s-0032-1315433

  20. Shorvon S, Ferlisi M. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain [Internet]. 2012 [cited 2013 Mar 28];135(8):2314-28. Available from: http://brain.oxfordjournals.org/content/135/8/2314.long

  21. Johnson RC, Young SK, Cotter R, Lin L, Rowe WB. Medium-chain-triglyceride lipid emulsion: metabolism and tissue distribution. Am J Clin Nutr. 1990;52:502-8.

  22. Stafstrom CE. Animal models of the ketogenic diet: what have we learned, what can we learn? Epilepsy Res. 1999;37:241-59.




2020     |     www.medigraphic.com